Drug Type Synthetic peptide |
Synonyms EB-203, EB203 |
Target- |
Mechanism Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H50N8O12 |
InChIKeyZCBOYEVKQWTKJZ-XSEPRYCASA-N |
CAS Registry2559326-61-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Phase 1 | KR | 29 Jun 2022 | |
Wet Macular Degeneration | Phase 1 | KR | 29 Jun 2022 |